Hydrogel containing adapalene- and dapsone-loaded lipid-core nanocapsules for cutaneous application: development, characterization, in vitro irritation and permeation studies
- 31 May 2016
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 42 (12) , 2001-2008
Abstract
Lipid-core polymeric nanocapsule suspensions containing adapalene and dapsone (AD-LCNC) were developed and incorporated in a Carbopol 940® hydrogel (AD-LCNC HG). A nanoemulsion (AD-NE), similarly prepared but omitting the polymer, was developed and also incorporated in a Carbopol 940® hydrogel (AD-NE HG) to evaluate the polymer effect. Physicochemical characteristics were evaluated. AD-LCNC suspensions containing 0.07% of dapsone and 0.025% of adapalene presented an average size of 194.9 ± 0.42 nm, zeta potential of −15 ± 1.2 mV and polydispersity index of 0.12 ± 0.02, using electrophoretic light scattering (n = 3). The granulometric profiles showed unimodal size distributions for AD-LCNC suspensions, demonstrating that no microscopic population is present in the formulation. No instability phenomena were observed by multiple light-scattering analysis. Photomicrographs obtained by TEM showed homogeneous- and spherical-shaped particles. The encapsulation efficiency was 99.99% for dapsone and 100% for adapalene. The pH values for AD-LCNC suspensions were 5.1 and 7.6 for AD-LCNC HG. Formulations were classified as nonirritant in the HET-CAM test. Rheological analysis demonstrated a non-Newtonian pseudoplastic profile. The in vitro skin permeation studies showed a higher amount of adapalene in epidermis (130.52 ± 25.72 ng/mg) and dermis (4.66 ± 2.5 ng/mg) for AD-NE HG. The AD-LCNC HG presented higher amount of dapsone in both the skin layers (73.91 ± 21.64 ng/mg in epidermis and 4.08 ± 0.85 ng/mg in dermis). The assay showed significant difference between AD-LCNC HG and AD-NE HG (p < 0.05), and drug was not found in the receptor medium.Keywords
This publication has 30 references indexed in Scilit:
- Acne vulgarisThe Lancet, 2012
- Acne Vulgaris: Pathogenesis, Treatment, and Needs AssessmentDermatologic Clinics, 2012
- Improved photostability and reduced skin permeation of tretinoin: Development of a semisolid nanomedicineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Topical Application of Nanostructures: Solid Lipid, Polymeric and Metallic Nanoparticles2011
- Polymeric Nanocapsules: Concepts and Applications2011
- What's new in acne? New therapeutic approachesAnnales de Dermatologie et de Vénéréologie, 2010
- Polymer-based nanocapsules for drug deliveryInternational Journal of Pharmaceutics, 2010
- Evidence for Laser- and Light-Based Treatment of Acne VulgarisSeminars in Cutaneous Medicine and Surgery, 2008
- The prevalence of acne in adults 20 years and olderJournal of the American Academy of Dermatology, 2008
- Novel Drug Delivery Systems: Potential in Improving Topical Delivery of Antiacne AgentsSkin Pharmacology and Physiology, 2005